Relation Between Red Cell Distribution Width and Clinical Outcomes After Acute Myocardial Infarction

American Journal of Cardiology

Volumn 105, Issue 3, 2010, Pages 312-317

  Dabbah, Saleem ^a   Hammerman, Haim ^a   Markiewicz, Walter ^a   Aronson, Doron ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE HEART INFARCTION; ADULT; ADVERSE OUTCOME; ANEMIA; ARTICLE; CORONARY ARTERY DISEASE; DEATH; ERYTHROCYTE; ERYTHROCYTE VOLUME; FEMALE; HEART FAILURE; HEART MUSCLE REVASCULARIZATION; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN DETERMINATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INCIDENCE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RED BLOOD CELL DISTRIBUTION WIDTH; RISK;

ADULT; AGED; CONFIDENCE INTERVALS; ERYTHROCYTE INDICES; ERYTHROCYTES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INPATIENTS; ISRAEL; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 74349085669     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.09.027     Document Type: Article

References (26)

1. Simel D.L., DeLong E.R., Feussner J.R., Weinberg J.B., and Crawford J. Erythrocyte anisocytosis. Visual inspection of blood films vs automated analysis of red blood cell distribution width. Arch Intern Med 148 (1988) 822-824
2. Felker G.M., Allen L.A., Pocock S.J., Shaw L.K., McMurray J.J., Pfeffer M.A., Swedberg K., Wang D., Yusuf S., Michelson E.L., and Granger C.B. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol 50 (2007) 40-47
3. Tonelli M., Sacks F., Arnold M., Moye L., Davis B., and Pfeffer M. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation 117 (2008) 163-168
4. Cavusoglu E., Chopra V., Gupta A., Battala V.R., Poludasu S., Eng C., and Marmur J.D. Relation between red blood cell distribution width (RDW) and all-cause mortality at two years in an unselected population referred for coronary angiography. Int J Cardiol (2009)
5. Aronson D., Dann E.J., Bonstein L., Blich M., Kapeliovich M., Beyar R., Markiewicz W., and Hammerman H. Impact of red blood cell transfusion on clinical outcomes in patients with acute myocardial infarction. Am J Cardiol 102 (2008) 115-119
6. Aronson D., Suleiman M., Agmon Y., Suleiman A., Blich M., Kapeliovich M., Beyar R., Markiewicz W., and Hammerman H. Changes in haemoglobin levels during hospital course and long-term outcome after acute myocardial infarction. Eur Heart J 28 (2007) 1289-1296
7. Alpert J.S., Thygesen K., Antman E., and Bassand J.P. Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36 (2000) 959-969
8. World Health Organization. Nutritional Anemia: Report of a WHO Scientific Group World Health Organization (1968), World Health Organization, Geneva
9. Guralnik J.M., Eisenstaedt R.S., Ferrucci L., Klein H.G., and Woodman R.C. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood 104 (2004) 2263-2268
10. Lauer M.S., Blackstone E.H., Young J.B., and Topol E.J. Cause of death in clinical research: time for a reassessment?. J Am Coll Cardiol 34 (1999) 618-620
11. Karnad A., and Poskitt T.R. The automated complete blood cell count. Use of the red blood cell volume distribution width and mean platelet volume in evaluating anemia and thrombocytopenia. Arch Intern Med 145 (1985) 1270-1272
12. Thompson W.G., Meola T., Lipkin Jr. M., and Freedman M.L. Red cell distribution width, mean corpuscular volume, and transferrin saturation in the diagnosis of iron deficiency. Arch Intern Med 148 (1988) 2128-2130
13. Comeaux L., Fife D.J., and McKenzie S.B. Instructor's Guide for Clinical Laboratory Hematology (2004), Pearson/Prentice-Hall, Upper Saddle River, NJ
14. Aslan D., Gumruk F., Gurgey A., and Altay C. Importance of RDW value in differential diagnosis of hypochrome anemias. Am J Hematol 69 (2002) 31-33
15. Bessman J.D., Gilmer Jr. P.R., and Gardner F.H. Improved classification of anemias by MCV and RDW. Am J Clin Pathol 80 (1983) 322-326
16. Sabatine M.S., Morrow D.A., Giugliano R.P., Burton P.B., Murphy S.A., McCabe C.H., Gibson C.M., and Braunwald E. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 111 (2005) 2042-2049
17. Rao S.V., Eikelboom J.A., Granger C.B., Harrington R.A., Califf R.M., and Bassand J.P. Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes. Eur Heart J 28 (2007) 1193-1204
18. Tracey K.J., Wei H., Manogue K.R., Fong Y., Hesse D.G., Nguyen H.T., Kuo G.C., Beutler B., Cotran R.S., Cerami A., and Lowry S.F. Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J Exp Med 167 (1988) 1211-1227
19. Nemeth E., Rivera S., Gabayan V., Keller C., Taudorf S., Pedersen B.K., and Ganz T. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 113 (2004) 1271-1276
20. Ferrario M., Massa M., Rosti V., Campanelli R., Ferlini M., Marinoni B., De Ferrari G.M., Meli V., De Amici M., Repetto A., Verri A., Bramucci E., and Tavazzi L. Early haemoglobin-independent increase of plasma erythropoietin levels in patients with acute myocardial infarction. Eur Heart J 28 (2007) 1805-1813
21. Kato H., Ishida J., Imagawa S., Saito T., Suzuki N., Matsuoka T., Sugaya T., Tanimoto K., Yokoo T., Ohneda O., Sugiyama F., Yagami K., Fujita T., Yamamoto M., Nangaku M., and Fukamizu A. Enhanced erythropoiesis mediated by activation of the renin-angiotensin system via angiotensin II type 1a receptor. FASEB J 19 (2005) 2023-2025
22. Cole J., Ertoy D., Lin H., Sutliff R.L., Ezan E., Guyene T.T., Capecchi M., Corvol P., and Bernstein K.E. Lack of angiotensin II-facilitated erythropoiesis causes anemia in angiotensin-converting enzyme-deficient mice. J Clin Invest 106 (2000) 1391-1398
23. Gossmann J., Burkhardt R., Harder S., Lenz T., Sedlmeyer A., Klinkhardt U., Geiger H., and Scheuermann E.H. Angiotensin II infusion increases plasma erythropoietin levels via an angiotensin II type 1 receptor-dependent pathway. Kidney Int 60 (2001) 83-86
24. Brown J.E., and Adamson J.W. Modulation of in vitro erythropoiesis. The influence of beta-adrenergic agonists on erythroid colony formation. J Clin Invest 60 (1977) 70-77
25. Mladenovic J., and Adamson J.W. Adrenergic modulation of erythropoiesis: in vitro studies of colony-forming cells in normal and polycythaemic man. Br J Haematol 56 (1984) 323-332
26. Lin J.P., O'Donnell C.J., Jin L., Fox C., Yang Q., and Cupples L.A. Evidence for linkage of red blood cell size and count: genome-wide scans in the Framingham Heart Study. Am J Hematol 82 (2007) 605-610